Therapy Areas in Europe

Good health and wellbeing is a universal aspiration, and we continue to seek ways to help patients in achieving better health and a better quality of life. In Europe our pharmaceutical business employs around 500 people, all of whom channel their energy into exploring solutions that we hope will make a difference to patients’ lives. We aim to help people with diseases that range from those affecting millions to those that affect relatively few. The health and wellbeing of patients is our primary focus, and we put the needs and views of patients, carers and healthcare professionals at the heart of the work we do. We aim to help patients in the following therapy areas:

Neuroscience

For over 30 years, we have worked in the area of mental health, focusing on treatments for schizophrenia and bipolar disorder.

Haemato-oncology

We are currently focusing on haematological malignancies, such as acute myeloid leukaemia.

Digital Therapeutics

We are exploring how digital health technology may provide holistic health solutions for patients, carers and healthcare professionals.